Multiple Sclerosis Therapeutics Market Worth US$ 39,223.59 million by 2027

1
Multiple Sclerosis Therapeutics Market 
Multiple Sclerosis Therapeutics Market Forecast
to 2027 - COVID-19 Impact and Global Analysis By
Drug Class (Immunosuppressant and
Immunomodulators), Route of Administration
(Injectable and Oral), and Distribution Channel
(Hospital Pharmacies, Retail Pharmacies, and
E-Commerce), and Geography
2
Current and future Market Scenario
Multiple Sclerosis Therapeutics Market 

• The Multiple Sclerosis Therapeutics Market was
  valued at US 24,026.90 million in 2019 and it is
  projected to reach US 39,223.59 million by 2027
  it is expected to grow at a CAGR of 6.5 from
  2020 to 2027.

3
Market Segments

• Food Service
• Food Retail

Multiple Sclerosis Therapeutics Market   
By Drug Class Immunosuppressant Immunomodulators
Others
By Route of Administration Injectable Oral
Others
By Distribution Channel Hospital
Pharmacies Retail Pharmacies E-Commerce Others
4
Leading Players
Multiple Sclerosis Therapeutics Market  
Company Profiles in Multiple Sclerosis
Therapeutics Market are Merck Co., Inc.
Novartis AG Bayer AG
Sanofi Bristol-Myers Squibb Company
Horizon Therapeutics plc. TEVA
PHARMACEUTICAL INDUSTRIES LTD Takeda
Pharmaceutical Company Limited F.
HOFFMANN-LA ROCHE LTD. Biogen
5
Multiple Sclerosis Therapeutics
Market  
Access Full Research Report at
https//www.theinsightpartners.com/reports/multipl
e-sclerosis-therapeutics-market
Thank You!

• Thank You!